Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 2/22/24 → 2/22/26 |
Funding
- UCB Biopharma SRL (Belgium): $18,382.00
PD0060: Multicenter Phase 2, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetcis of UCB0022 in Study Participants with Advanced Parkinson's Disease
- Slevin, John (PI)